Overexpression of podocalyxin in megakaryocytes and platelets decreases the bleeding time and enhances the agonist-induced aggregation of platelets

被引:8
作者
Alonso-Martin, Sonia [1 ]
Nowakowski, Adam [2 ]
Larrucea, Susana [1 ]
Fernandez, Dario [2 ]
Vilar-Egea, Maripaz [1 ,2 ]
Ayuso, Matilde S. [1 ,2 ]
Parrilla, Roberto [1 ,2 ]
机构
[1] CSIC, Ctr Invest Biol, Dept Physiopathol, Madrid 28040, Spain
[2] CIBERER, Madrid, Spain
关键词
Platelets; Bleeding time; Transgenic mice; Podocalyxin; MICE LACKING; MAJOR SIALOPROTEIN; EXPRESSION; PROTEIN; IDENTIFICATION; ADHESION; MARKER; CANCER; CELLS;
D O I
10.1016/j.thromres.2010.02.008
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Podocalyxin (PODXL) is a 145 KDa sialoprotein abundantly expressed in the glycocalix of the intraglomerular kidney epithelial cells, essential in maintaining a normal renal function. PODXL is also found in vascular endothelial cells, megakaryocytes and platelets. The function of PODXL in platelets is ignored; however, its surface exposure upon platelet activation suggests its participation in controlling the hemostasis. We have generated mice (pr alpha IIb-PODXL) overexpressing PODXL specifically in megakaryocytes, either alone or as a fusion protein with green fluorescent protein. The transgenic mice showed a phenotype characterized by decreased bleeding time, mild rebleeding and enhanced platelets aggregation upon agonist stimulation. The cytohematological exams as well as the prothrombin time (PT) and (APTT) tests did not differ from the control group. The biochemical analysis showed only a discrete hyperlipemia and a rise in plasma uric acid levels in the transgenic mice. The present data seem to indicate that PODXL may act as a costimulator of agonists in the activation of platelets and formation of a stable thrombus. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:E300 / E305
页数:6
相关论文
共 32 条
[1]
Adhesion of activated platelets to endothelial cells:: Evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), αvβ3 integrin, and GPIbα [J].
Bombeli, T ;
Schwartz, BR ;
Harlan, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (03) :329-339
[2]
CARTER JW, 1989, EUR J APPL PHYSL, V59, P1439
[3]
Podocalyxin variants and risk of prostate cancer and tumor aggressiveness [J].
Casey, G ;
Neville, PJ ;
Liu, X ;
Plummer, SJ ;
Cicek, MS ;
Krumroy, LM ;
Curran, AP ;
McGreevy, MR ;
Catalona, WJ ;
Klein, EA ;
Witte, JS .
HUMAN MOLECULAR GENETICS, 2006, 15 (05) :735-741
[4]
CAULFIELD JP, 1976, LAB INVEST, V34, P43
[5]
SULFATE CONTRIBUTES TO THE NEGATIVE CHARGE OF PODOCALYXIN, THE MAJOR SIALOGLYCOPROTEIN OF THE GLOMERULAR-FILTRATION SLITS [J].
DEKAN, G ;
GABEL, C ;
FARQUHAR, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5398-5402
[6]
Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells [J].
Doyonnas, R ;
Nielsen, JS ;
Chelliah, S ;
Drew, E ;
Hara, T ;
Miyajima, A ;
McNagny, KM .
BLOOD, 2005, 105 (11) :4170-4178
[7]
Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin [J].
Doyonnas, R ;
Kershaw, DB ;
Duhme, C ;
Merkens, H ;
Chelliah, S ;
Graf, T ;
McNagny, KM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (01) :13-27
[8]
Fattorutto M, 2004, CAN J ANAESTH, V51, P672, DOI 10.1007/BF03018424
[9]
Freedman JE, 1999, CIRC RES, V84, P1416
[10]
The Ashwell receptor mitigates the lethal coagulopathy of sepsis [J].
Grewal, Prabhjit K. ;
Uchiyama, Satoshi ;
Ditto, David ;
Varki, Nissi ;
Le, Dzung T. ;
Nizet, Victor ;
Marth, Jamey D. .
NATURE MEDICINE, 2008, 14 (06) :648-655